Home/Filings/4/0001209191-22-008580
4//SEC Filing

TIDMARSH GEORGE F 4

Accession 0001209191-22-008580

CIK 0001810560other

Filed

Feb 9, 7:00 PM ET

Accepted

Feb 10, 6:22 PM ET

Size

7.4 KB

Accession

0001209191-22-008580

Insider Transaction Report

Form 4
Period: 2022-02-08
Transactions
  • Purchase

    Common Stock

    2022-02-08$2.54/sh+1,000$2,540417,156 total
  • Purchase

    Common Stock

    2022-02-09$2.55/sh+30,000$76,599447,156 total
Holdings
  • Common Stock

    (indirect: By Trust)
    1,523,335
Footnotes (2)
  • [F1]Represents the weighted-average price at which shares were purchased within a range between $2.53 and $2.57. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
  • [F2]Shares are held by George Tidmarsh, Trustee George Francis Tidmarsh 2021 Irrevocable Trust with respect to which George Tidmarsh is a trustee.

Issuer

REVELATION BIOSCIENCES, INC.

CIK 0001810560

Entity typeother

Related Parties

1
  • filerCIK 0001287235

Filing Metadata

Form type
4
Filed
Feb 9, 7:00 PM ET
Accepted
Feb 10, 6:22 PM ET
Size
7.4 KB